Argent BioPharma Limited (ASX:RGT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0940
+0.0040 (4.44%)
At close: Jun 6, 2025, 4:00 PM AEST

Argent BioPharma Market Cap

Argent BioPharma has a market cap or net worth of 6.79 million as of June 6, 2025. Its market cap has decreased by -62.06% in one year.

Market Cap
6.79M
Enterprise Value
15.42M
Revenue
295.83K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09

Market Cap Chart

Since September 28, 2012, Argent BioPharma's market cap has decreased from 31.18M to 6.79M, a decrease of -78.24%. That is a compound annual growth rate of -11.32%.

History

DateMarket Cap% Change
Jun 6, 20256.79M-26.46%
Dec 31, 20249.23M-46.77%
Dec 29, 202317.33M-45.96%
Dec 30, 202232.07M-67.88%
Dec 31, 202199.85M123.36%
Dec 31, 202044.70M1.89%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CSL Limited 117.14B
Pro Medicus 28.83B
Cochlear 17.56B
Sonic Healthcare 12.67B
Ramsay Health Care 8.65B
Telix Pharmaceuticals 8.64B
Ansell 4.51B
Regis Healthcare 2.27B
Market Cap Rankings